Coronary revascularization: Clinical features and indications;Indicaciones de revascularización: Aspectos clínicos

Revista Espanola de Cardiologia

Volumn 58, Issue 2, 2005, Pages 198-216

  Alonso Martín, Joaquín J ^a   Curcio Ruigómez, Alejandro ^a   Cristóbal Varela, Carmen ^a   Tarín Vicente, María Nieves ^a   Serrano Antolín, José María ^a   Talavera Calle, Pedro ^a   Graupner Abad, Catherine ^a  

^a HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

Author keywords

Acute coronary syndrome without ST segment elevation; Coronary angioplasty; Coronary artery bypass grafting; Coronary revascularization; Percutaneous coronary intervention; Stable angina

Indexed keywords

ACUTE DISEASE; AGE; CLINICAL FEATURE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; ECG ABNORMALITY; EVIDENCE BASED MEDICINE; GENDER; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PATIENT SELECTION; PRACTICE GUIDELINE; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 15944412811     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13071894     Document Type: Review

References (85)

1. Vineberg A, Millar G. Internal mammary coronary anastomosis in the surgical treatment of coronary artery insufficiency. Can Med Assoc J. 1951;64:204-10.
2. Kolesov VI, Porashov LV. Surgery of coronary arteries. Eksp Khir Anesteziol. 1965;10:3-8.
3. Favaloro RG. Saphenous vein graft in the surgical treatment of coronary artery diseases: operative technique. J Thorac Cardiovasc Surg. 1969;58:178-85.
4. Grüntzig A, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61-8.
5. Igual A, Saura E. Cirugía cardiovacular in el año 2002. Registro de Intervenciones de la Sociedad Española de Cirugía Cardiovascular. Cir Cariov. 2004;11:97-108.
6. López-Palop R, Moreu J, Fernández-Váquez F, Hernández R. Registro Español de Hemodinámica y Cardiología Intervencionista. XIII Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2003). Rev Esp Cardiol. 2004;57:1076-89.
7. Chaitman BR, Fisher LD, Bourassa MG, Davis K, Rogers WJ, Maynard C, et al. Effects of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease: report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol. 1981;48:765-77.
8. Myers WO, Schaff HV, Gersh BJ, Fisher LD, Kosinski AS, Mock MB, et al. Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris: a report from the Coronary Artery Surgical Study (CASS) registry. J Thorac Cardiovasc Surg. 1989;97:487-95.
9. Califf RM, Mark DB, Harrell FE Jr, Hlatky MA, Lee KL, Rosati RA, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol. 1988;11:20-6.
10. Weiner DA, Ryan TJ, McCabe CH, Chaitman BR, Sheffield LT, Ferguson JC, et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol. 1984;3:771-9.
11. Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham study: prognosis and survival. Am J Cardiol. 1972; 29:154-63.
12. Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. The West of Scotland Coronary Prevention Study Group. Am J Cardiol. 1997; 79:756-62.
13. Eleven-year survival in the Veterans Admisitration randomized trial of coronary bypass surgery for stable angina. the Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984;311:1333-9.
14. Miranda CP, Lehmann KG, Froelicher VF. Correlation between resting segment depression, exercise testing, coronary angiography and long-term prognosis. Am Heart J. 1991;122:1617-28.
15. Califf RM, Phillips HR 3rd, Hindman MC, Mark DB, Lee KL, Behar VS, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055-63.
16. Proudfit WJ, Bruschke AV, MacMillan JP, Williams GW, Sones FM Jr. Fifteen year survival study of patients with obstructive coronary artery disease. Circulation. 1983;68:986-97.
17. Mark DB, Shaw L, Harrell FE Jr, Hlatky MA, Lee KL, Bengtson JR, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991;325:849-53.
18. Weiner DA, Ryan TJ, McCabe CH, Chaitman BR, Sheffield LT, Fisher LD, et al. Value of exercise testing in determining the risk classification and the response to coronary artery bypass grafting in three-vessel coronary artery disease: a report from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol. 1987; 60:262-6.
19. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigatiors. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med. 1998;339:436-43.
20. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet. 1999;354:708-15.
21. Cannon CP, Weintraub WS, Demopoulus LA, Vicari R, Frey MJ, Lakkis A, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87.
22. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet. 2002;360:743-51.
23. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic dicision making. JAMA. 2000;284:835-42.
24. López Bescós L, Arós Borau F, Lidón Corbi RM, Cequier Fillat A, Bueno H, Alonso JJ, et al. Actualización (2002) de la Guías de Práctica Clínica de la Sociedad Española de Cardiología en angina inestable/infarto sin elevación del segmento ST. Rev Esp Cadiol. 2002;55:631-42.
25. Bertrand ME, Simoons ML, Fox KAA, Wallentin LC, Hamm CW, McFadden E, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J. 2002;23:1809-40.
26. San Román JA, Tejedor P, Wu E, Sierra J. Nuevas ténicas de imagen en la valoración de los pacientes con un síndrome coronario agudo. En: Alonso JJ, editor. Manual del síndrome coronario agudo. Madrid: Scientific Communication Management y Sociedad Española de Cardiología;2001.p. 323-40.
27. Arós F, Boraita A, Alegría E, Alonso AM. Bardaji A, Lamiel R. Guías de práctica clínica de la Sociedad Española de Cardiología sobre pruebas de esfuerzo. Rev Esp Cardiol. 2000;53:1063-94.
28. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, et al Noninvasive diagnosis of ischemia-induced wall motion abnormalities with dobutamine stress echocardiography. Circulation 1999;99:763-70.
29. Pennell DJ, Brady TJ, Pyket IL, Buro CT, Bounanno FS, Kistler JP, et al. Quantification of experimental myocardial infartion using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation. 1982; 66:1012-6.
30. Wagner A, Mahrholdt H, Holly TA, Elliot MD, Regerfus M, Parker M, et al. Contrast-enhanced MRI and routine single photonemission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocadial infarcts: an imaging study. Lancet 2003:361;374-9.
31. Araujo LI. Elementos diagnósticos no invadivos en la evaluación de la viabilidad miocárdica: una continua búsqueda. Rev Esp Cardiol. 2000;53:896-8.
32. Redwood SR, Ferrari R, Marber MS. Myocardial hibernation and stunning: from physiological principles to clinical practice. Heart. 1998;80:218-22.
33. Jiménez Borreguero LJ, Ruiz-Salmerón R. Valoración de la viabilidad miocardica en pacientes prerrevascularización. Rev Esp Cardiol. 2003;56:721-33.
34. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplaty. Circulation. 1995;91:663-70.
35. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1159-62.
36. Jacobs AK, Johnston JM, Haviland A, Brooks MM, Kelsey SF, Holmes DR Jr, et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dysnamic Registry. J Am Coll Cardiol. 2002;39:1608-14.
37. Jacobs AK, Kelsey SF, Brooks MM, Faxon DP, Chaitman BR, Bittner V, et al. Better outcome for women compared with men undergoing coronary revacularization: a report from the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1998;98:1279-85.
38. Effects of tissue plaminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI-IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994; 89:1545-56.
39. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Keriakes D, Ken MJ, et al. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committe to revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol. 2001; 37:2215-38.
40. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology Web Site. Disponible en:www.acc.org/clinical/guidelines/cabg/index.pdf
41. Alonso JJ, Durán JM, Gimeno F, Ramos B, Serrador A, Fernández-Avilés F. Angioplastia coronaria en el paciente diabético. Situación actual y perspectivas futuras. Rev Esp Cardiol. 2002; 55:1185-2000.
42. Barzilay JI, Kkronmal RA, Bittnar V, Eaker E, Evans C, Foster ED. Coronary artery disease and coronary artery bypass grafting in diabetics aged = 65 years (report from the Coronary Artery Sergery Study [CASS] registry). Am J Cardiol. 1994;74:334-9.
43. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Crurrier JW, for the investigators of the NHLBI PTCA Registry. Coronary angioplasty in diabetic patients: the National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:1818-25.
44. Stein B, Weintraub WS, Gebhart SSP, Cohen-Bernstein CI, Grosswald R, Liberman HA, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-89.
45. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217-25.
46. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96:1761-9.
47. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessels coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation. 2001;104:533-8.
48. Foley RN, Palfrey PS, Saran MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32 Suppl 3:112-9.
49. Reis G, Marcovitz PA, Leichtman AB, Merion RM, Fay WP, Werns SW, et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol. 1995;75:707-10.
50. Schoebel FC, Gradaus F, Ivens K, Heering P, Jax TW, Grabensee B, et al. Restenosis after elective coronary balloon angioplaty in patients with end-stage renal disease: a case control study using quantitative coronary angiography. Heart. 1997;78:337-42.
51. Le Feuvre C, Dambrin G, Helft G, Beygui F, Touam M, Grunfeld JP, et al. Clinical outcome following coronary angioplasty in sialysis patients: a case control study in the era of coronary stenting. Heart. 2001;85:556-60.
52. Gupta R, Birnbaum Y, Urestky BF. The renal patient with coronary artery disease: current concepts and dilemas. J Am Coll Cardiol. 2004;44:1343-53.
53. Dacey LJ, Liu JY, Braxton JH, Weintraub RM, DeSimone J, Charlesworth DC, et al. Long-term survival of dyalisis patients after coronary bypass grafting. Ann Thorac Surg. 2002;74:458-63.
54. Szczech LA, Best PJ, Crowley E, Brooks MM, Berger PB, Bittner V, et al, for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation. 2002;105:2253-8.
55. Ix JH, Mercado N, Shlipak MG, Boersma E, Lemos PA, Lindenboom W, et al. The Effects of renal insufficiency on clinical outcomes after coronary revascularization in patients with multivessel disease: the Arterial Revascularization Therapies Study (ARTS). Circulation. 2002;106 Suppl II:II492.
56. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer M. Prospective analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004; 109:9043-4.
57. Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nessen SE. Ability of troponins to predict adverse outcome in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol. 1999;33: 471-8.
58. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of Long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol. 2003;92:509-14.
59. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988; 319:332-7.
60. Muhlbaier LH, Pryor DB, Randin JS. Observational comparison of event-free survival with medical and surgical theraphy in patients with coronary artery disease. 20 years of follow-up. Circulation. 1992;86 Suppl II:198-204.
61. Rahimtoola SH, Bennett AJ, Grunkemeier GL, Block P, Starr A. Survival at 15 to 18 years after coronary bypass surgery for angina in women. Circulation 1993;88 Suppl II:71-8.
62. Sergeant P, Lesaffre E, Flameng W, Suy R, Blackstone E. The return of clinically evident ischemia after coronary artery bypass grafting. Eur J Cardiothorac Surg. 1991;5:447-57.
63. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, et al, Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629-46.
64. Parisi AF, Folland DE, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med. 1992;326:10-6.
65. Hartigan PM, Giacomini JC, Folland ED, Parisi AF. Two-to-three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine. Am J Cardiol. 1998;82:1445-50.
66. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461-8.
67. Pitt B, Waters D, Brown WV, Van Boven AJ, Schwartz L, Title LM et al. Results of the Atorvastatin Versus Revacularization Treatments (AVERT) Study: an 18-month study of aggressive lipid lowering in patients with stable coronary artery disease indicated for a catheter-based revascularization. Presentado en 71st Scientific Sessions of the American Heart Association. 9-12 de noveimber de 1998. Dallas.
68. Knatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chaitman BR, et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the asymptomatic cardiac ischemica pilot (ACIP) study. J Am Coll Cadiol. 1994;24:11-20.
69. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, et al. Asymtomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization J Am Coll Cardiol. 1995;26:594-605.
70. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10 years results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-70.
71. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, for the FRISC investigators. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease: the FRISC II invasive randomised trial. Lancet. 2000;356:9-16.
72. Van't Hof AW, De Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, et al. A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early of Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. Eur Heart J. 2003;24:1401-5.
73. Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, Bestehorn HP, et al. Evaluation of prolonged antithrombotic pretreatment («cooling-off» strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290:1593-9.
74. Esplugas E, Alfonso F, Alonso JJ, Asín E, Elizaga J, Iñíguez A, et al. Guías de prática clínica de la Sociedad Española de Cardiología en cardiología intervencionista: angioplastia coronaria y otras tćnicas. Rev Esp Cardiol. 2000;53:218-40.
75. Alonso JJ, Azpitarte J, Bardaji A, Cabadés A, Fernández A, Palencia M, et al. Guías de Práctica clínica de la Sociedad Española de Cardiología en cirugía coronaria. Rev Esp Cardiol. 2000; 53:241-66.
76. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB 3rd, Hamm CW, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995; 346:1184-9.
77. Sim I, Gupta M, McDonald K, Bourassa MG, Hlatky MA, A meta-analysis of randomised trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessels coronary artery disease. Am J Cardiol. 1995; 76:1025-9.
78. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 2000;35:1122-9.
79. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, et al, for the Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001; 344:1117-24.
80. Serruys PW, Ong AT, Van Herwerden LA, Sousa EJ, Jatene A, Bonnier JR, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the ARTS trial. Circulation. 2004;110 Suppl III:III-419.
81. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360:965-70.
82. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F. Sedlis S, et al. for the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trials. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol. 2001;38:143-9.
83. Goy JJ, Kaufmann U, Goy-Eggenberger D, Garachemani A, Hurni M, Carrel T, et al. A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal. isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc. 2000; 75:1116-23.
84. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, et al. Argentine Randomized Study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol. 2001;37:51-8.
85. Diegeler A, Thiele H, Falk V, Hambrecht R, Spyrantis N, Sick P, et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med. 2002;347:561-6.